Longitudinal changes in magnetisation transfer ratio in secondary progressive multiple sclerosis: data from a randomised placebo controlled trial of lamotrigine.

Hayton, T; Furby, J; Smith, K J; Altmann, D R; Brenner, R; Chataway, J; Hunter, K; Tozer, D J; Miller, D H; Kapoor, R

Hayton, T; Furby, J; Smith, K J; Altmann, D R; Brenner, R; Chataway, J; Hunter, K; Tozer, D J; Miller, D H; Kapoor, R.

Affiliation

Hayton T; Department of Neuroinflammation, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK. t.hayton@ion.ucl.ac.uk

J Neurol ; 259(3): 505-14, 2012 Mar.

Article in En | MEDLINE | ID: mdl-21904901

Subject(s)

Calcium Channel Blockers/therapeutic use; Magnetic Resonance Imaging; Multiple Sclerosis, Chronic Progressive/drug therapy; Triazines/therapeutic use; Adult; Disability Evaluation; Double-Blind Method; Female; Humans; Lamotrigine; Longitudinal Studies; Magnetic Resonance Imaging/methods; Male; Middle Aged; Reproducibility of Results; Severity of Illness Index; Time Factors

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Triazines / Magnetic Resonance Imaging / Calcium Channel Blockers / Multiple Sclerosis, Chronic Progressive Type of study: Clinical_trials / Observational_studies / Prognostic_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: J Neurol Year: 2012 Type: Article Affiliation country: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google